Evidence map›Paper›PMID 35619074›Full record

ArticleBMC musculoskeletal disorders2022

Factors associated with physician-reported treatment status of patients with osteoarthritis pain.

Thomas J Schnitzer, Rebecca L Robinson, Leslie Tive, Joseph C Cappelleri, Andrew G Bushmakin, James Jackson, Mia Berry, Sophie Barlow, Chloe Walker, Lars Viktrup

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Thomas J SchnitzerNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
Rebecca L RobinsonValue, Evidence and Outcomes, Eli Lilly and Company, Lilly Research Labs, Lilly Corporate Center, Indianapolis, IN, 46285, USA. rlrobinson@lilly.com.
Leslie TiveInternal Medicine, Global Medical Affairs, Pfizer Inc, New York, NY, USA.
Joseph C CappelleriStatistical Research and Data Science Center, Pfizer Inc, New York, NY, USA.
Andrew G BushmakinStatistical Research and Data Science Center, Pfizer Inc, New York, NY, USA.
James JacksonReal World Research, Adelphi Real World, Bollington, UK.
Mia BerryReal World Research, Adelphi Real World, Bollington, UK.
Sophie BarlowReal World Research, Adelphi Real World, Bollington, UK.
Chloe WalkerReal World Research, Adelphi Real World, Bollington, UK.
Lars ViktrupNeuroscience, Eli Lilly and Company, Indianapolis, IN, USA.
Adelphi Group (United Kingdom) · GBPfizer (United States) · USEli Lilly (United States) · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOsteoarthritis (OA) is typically associated with pain, but many patients are not treated.

methodsThis point in time study explored factors associated with treatment status, using logistic regression of data from the Adelphi OA Disease Specific Programme conducted in the United States. Patients' treatment status was based on physician-reported, current: 1) prescription medication for OA vs. none; and 2) physician treatment (prescription medication and/or recommendation for specified nonpharmacologic treatment for OA [physical or occupational therapy, acupuncture, transcutaneous electrical nerve stimulation, or cognitive behavior therapy/psychotherapy]) vs. self-management (no prescription medication or specified nonpharmacologic treatment).

resultsThe 841 patients (including 57.0% knee OA, 31.9% hip OA) reported mild (45.4%) or moderate or severe (54.6%) average pain intensity over the last week. The majority were prescribed medication and/or recommended specified nonpharmacologic treatment; 218 were not prescription-medicated and 122 were self-managed. Bivariate analyses showed less severe patient-reported pain intensity and physician-rated OA severity, fewer joints affected by OA, lower proportion of joints affected by knee OA, better health status, lower body mass index, and lower ratings for cardiovascular and gastrointestinal risks, for those not prescribed medication (vs. prescription-medicated). Multivariate analyses confirmed factors significantly (p < 0.05) associated with prescription medication included (odds ratio): physician-rated current moderate OA severity (vs. mild, 2.03), patient-reported moderate OA severity 6 months ago (vs. mild, 1.71), knee OA (vs. not, 1.81), physician-recommended (0.28) and patient-reported (0.43) over-the-counter medication use (vs. not), prior surgery for OA (vs. not, 0.37); uncertain income was also significant. Factors significantly (p < 0.05) associated with physician treatment included (odds ratio): physician-recommended nonpharmacologic therapy requiring no/minimal medical supervision (vs. not, 2.21), physician-rated current moderate OA severity (vs. mild, 2.04), patient-reported over-the-counter medication use (vs. not, 0.26); uncertain time since diagnosis was also significant. Patient-reported pain intensity and most demographic factors were not significant in either model.

conclusionsApproximately 1 in 4 patients were not prescribed medication and 1 in 7 were self-managed, although many were using over-the-counter medications or nonpharmacologic therapies requiring no/minimal medical supervision. Multiple factors were significantly associated with treatment status, including OA severity and over-the-counter medication, but not pain intensity or most demographics.

Indexed as

Osteoarthritis, HipOsteoarthritis, KneePhysiciansHumansPainPain MeasurementUnited StatesOsteoarthritisPainPrescription analgesic medicationReal-world clinical practice

Identifiers

PMID35619074
PMCPMC9134575
OpenAlexW4281571470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.